Internal Medicine
Guideline Synopsis: The management of substance use disorders.
22 Mar, 2022 | 08:38h | UTC
Enabling patient choice: the “deciding not to decide” option for older adults facing dialysis decisions.
22 Mar, 2022 | 08:25h | UTCCommentary: The “Deciding Not to Decide” Option Can Improve Older Adult Patient Care – Rutgers University-New Brunswick
Investigating cognition in midlife.
22 Mar, 2022 | 08:13h | UTCInvestigating cognition in midlife – Alzheimer’s & Dementia
Evidence-based disposition of acute pancreatitis.
22 Mar, 2022 | 08:08h | UTCEvidence-Based Disposition of Acute Pancreatitis – emDocs
Related Guidelines:
Pancreatitis – National Institute for Health and Care Excellence
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
21 Mar, 2022 | 10:01h | UTC
Guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care.
21 Mar, 2022 | 10:02h | UTC
Infographic: IDSA COVID-19 outpatient treatment guidelines roadmap.
21 Mar, 2022 | 09:51h | UTCCOVID-19 Outpatient Treatment Guidelines Roadmap – Infectious Diseases Society of America
Commentary on Twitter
IDSA and @RealTimeCOVID19's new visual clinical flowchart summarizes outpatient COVID-19 treatment options and guidance.
📄:https://t.co/NTo1nNlfDr #RealTimeCOVID19 @CDCgov pic.twitter.com/CXz1tgpJ05
— IDSA (@IDSAInfo) March 19, 2022
RCT: Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome: a randomized trial of traditional dietary advice, the low FODMAP diet and the gluten-free diet.
21 Mar, 2022 | 08:53h | UTCCommentary: Traditional Dietary Advice Optimal as an Irritable Bowel Syndrome Therapy – HCPLivre
Related:
10 mistakes in dietary management of irritable bowel syndrome and how to avoid them.
Supplement: Irritable bowel syndrome and related conditions.
RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Guidelines for the treatment of irritable bowel syndrome
ACG Clinical Guideline: Management of irritable bowel syndrome
M-A: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome
Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.
21 Mar, 2022 | 09:37h | UTCMyocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel – JAMA
Related:
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
ACS nutrition and physical activity guideline for cancer survivors.
21 Mar, 2022 | 08:51h | UTCPatient Page: Nutrition and Physical Activity Guideline for Cancer Survivors – CA: A Cancer Journal for Clinicians
Review: How to manage a high-output stoma.
21 Mar, 2022 | 08:44h | UTCHow to manage a high-output stoma – Frontline Gastroenterology
Commentary on Twitter
Access the latest #FGPapers online here now:https://t.co/c1Eu6jpZCa
This includes the paper 'How to manage a high-output stoma" by Dr Jeremy Nightingale via https://t.co/8Oc3kS6YIG@RMBeattie50 @OTavabie @Dr_Dee_Kumar @AusDrGupta @jennie_clough @AlenkaBrooks @PaedsRH pic.twitter.com/9DRNNu0ui1
— Frontline Gastro (@FrontGastro_BMJ) February 11, 2022
Review: Challenging management dogma where evidence is non-existent, weak or outdated.
21 Mar, 2022 | 08:55h | UTCChallenging management dogma where evidence is non-existent, weak or outdated – Intensive Care Medicine (if the link is paywalled, try this one)
Systematic Review: Strategies for using topical corticosteroids in children and adults with eczema.
21 Mar, 2022 | 08:33h | UTCStrategies for using topical corticosteroids in children and adults with eczema – Cochrane Library
Summary: What is the best way to use topical corticosteroids to treat people with eczema? – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1504548242738102273
Editorial | BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction.
21 Mar, 2022 | 08:31h | UTCOriginal Study: Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality – European Heart Journal (link to abstract – $ for full-text)
Guideline: Management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period.
18 Mar, 2022 | 09:39h | UTC
Commentary on Twitter
BREAKING 🔥
Antiplatelets, anticoagulants and #EndoscopyNew CPG & dissemination tool.
An @AmCollegeGastro @CanGastroAssn co-production @AmJGastro and #JCAG@GriLeont @BryanGSauer @NeenaSAbrahamMD @alan_barkun @ThrombosisCan @LorenLaine2 #JenTelfordhttps://t.co/Ijs4jgOkPC pic.twitter.com/uUfN2zj3RS
— Journal of the Canadian Assn of Gastroenterology (@JCanAssnGastro) March 17, 2022
M-A: Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxemic respiratory failure.
18 Mar, 2022 | 09:32h | UTCInvited Commentary: The pandemic and the great awakening in the management of acute hypoxaemic respiratory failure – The Lancet Respiratory Medicine
Related:
RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19.
RCT: Cocoa flavanol supplementation shows promise for the prevention of cardiovascular disease events.
18 Mar, 2022 | 08:54h | UTC
Commentary on Twitter (thread – click for more)
In @AJCNutrition: @HowardSesso, Dr. JoAnn Manson of @BWHDPM @BrighamWomens & colleagues report the main findings of the first ever randomized trial of a cocoa flavanol supplement on cardiovascular disease endpointshttps://t.co/0F5v8WqzdM and https://t.co/vA3wwT0Amw (1 of 5) pic.twitter.com/X08hiNUCzK
— Brigham and Women’s Research (@BrighamResearch) March 16, 2022
Maintaining oral hydration in older adults in surgical wards: a best practice implementation project.
18 Mar, 2022 | 08:50h | UTCMaintaining oral hydration in older adults in surgical wards: a best practice implementation project – JBI Evidence Implementation (free for a limited period)
Commentary on Twitter
A timely and relevant article on this #WDAD2022. It is essential that basic needs like hydration, nutrition, movement, and sleep are addressed to prevent and mitigate negative outcomes for older persons, especially those at risk for #delirium.#research #practice @JBI_EI https://t.co/YzRWMiVMKQ
— Andrea Rochon RN, PhD (@AndreaRochon) March 17, 2022
Hypertension in the hospitalized patient: an update
18 Mar, 2022 | 08:18h | UTCHypertension in the hospitalized patient: An update – Nefrología
Symptom management in patients with cirrhosis: a practical guide.
18 Mar, 2022 | 08:13h | UTCSymptom Management in Patients with Cirrhosis: a Practical Guide – Current Treatment Options in Gastroenterology (free for a limited period)
Commentary from the author on Twitter (thread – click for more)
Published today! @rrosenblattmd and I discuss treatment considerations in patients with cirrhosis, including ascites, encephalopathy, pruritus, muscle cramping, pain, depression/anxiety, fatigue, and appetite⬇️ #livertwitter #cirrhosis #ESLD https://t.co/qjPCX5YPP7
— Aly J. Kaplan, MD (@aly_kaplanMD) March 17, 2022
Cohort Study: Characteristics and outcomes of Type 2 myocardial infarction.
18 Mar, 2022 | 08:05h | UTCCharacteristics and Outcomes of Type 2 Myocardial Infarction – JAMA Cardiology (link to abstract – $ for full-text)
Commentaries:
Type 2 MI Not Uncommon in the Emergency Department – TCTMD
Type 2 Myocardial Infarction: Clinical Characteristics and Outcomes – American College of Cardiology
Commentary on Twitter
Among patients presenting with acute chest discomfort to the emergency department, tachyarrhythmias and hypertension are responsible for more than two thirds of type 2 myocardial infarction and result in a lower mortality compared to other triggers. https://t.co/ODMCmOjeQO
— JAMA Cardiology (@JAMACardio) March 10, 2022
RCT: Oral contezolid vs. linezolid in adults with complicated skin and soft tissue infections.
18 Mar, 2022 | 07:54h | UTCA Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link to abstract – $ for full-text)
Commentary on Twitter
Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
📌Non inferior
📌Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
📌QIDP https://t.co/wSvxUInnkZ— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) March 11, 2022
State of the Art Review: Recent advances in the diagnosis and management of cluster headache.
17 Mar, 2022 | 09:21h | UTCRecent advances in the diagnosis and management of cluster headache – The BMJ
2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play.
17 Mar, 2022 | 09:26h | UTCCommentaries:
ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology
ACC Releases Guidance on CV Issues With COVID-19 – TCTMD
Key Points: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19
Related:
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Commentary on Twitter (thread – click for more)
Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem
— American College of Cardiology (@ACCinTouch) March 16, 2022
Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.
17 Mar, 2022 | 09:12h | UTCEfficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine
Related: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.